Carl Griffin - Concepedia

Author

Carl Griffin

Also Known As

Alex Greninger, Alisha Lutat, Carl Griffin, Carl P. Griffin, Carl Patrick Griffin, Carlos Fierro, Mary B Manning, Robert Smith, Suresh Shah

Publications

617

Citations

H-Index

Concepts

All Affiliations

Carl Griffin is an author at Moderna Therapeutics (United States) specializing in vaccine safety, vaccination, and immunology.

#	Concept	H-Index	Publications	Citations
1	Medicine	2	2	111
2	Immunology	2	2	111
3	Precision Vaccinology	1	1	70
4	Vaccine Development	1	1	41
5	Viral Hepatitis	1	1	70

Carl Griffin

Publications

435

Citations

H-Index

Page 1

	Year	Citations
Safety, Tolerability, and Immunogenicity of a 20-Valent Pneumococcal Conjugate Vaccine (PCV20) in Adults 60 to 64 Years of Age Donald Hurley, Carl Griffin, Mariano Young, Clinical Infectious Diseases	2020	156
Evaluation of mRNA-1273 Vaccine in Children 6 Months to 5 Years of Age Evan J. Anderson, C. Buddy Creech, Vladimir Berthaud, New England Journal of Medicine	2022	136
Immunogenicity and safety of a tri-antigenic versus a mono-antigenic hepatitis B vaccine in adults (PROTECT): a randomised, double-blind, phase 3 trial Timo Vesikari, Joanne M. Langley, Nathan Segall, The Lancet Infectious Diseases VaccinationVaccine SafetyViral HepatitisMedicineImmunology	2021	70
Safety, tolerability, and immunogenicity of an adult pneumococcal conjugate vaccine, V116 (STRIDE-3): a randomised, double-blind, active comparator controlled, international phase 3 trial Heather Platt, Christopher Bruno, Erik Buntinx, The Lancet Infectious Diseases VaccinationVaccine SafetyVaccine DevelopmentInternational Phase 3Immunology	2024	41
Humoral Immunogenicity of the mRNA-1273 Vaccine in the Phase 3 Coronavirus Efficacy (COVE) Trial Hana M. El Sahly, Lindsey R. Baden, Brandon Essink, The Journal of Infectious Diseases	2022	19
Risk of COVID-19 after natural infection or vaccination Anne-Marie Rick, Matthew B. Laurens, Ying Huang, EBioMedicine	2023	13

Page 1